Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Stolfo

Showing results (191-200 of 201) with videos related to

Pageof 21
Sort By:
Circulation. Arrhythmia and Electrophysiology|January 29, 2026
Left Ventricular Late Gadolinium Enhancement for Arrhythmic Risk Prediction in ARVCCorrado De Marco, Babken Asatryan, Anneline S J M Te Riele, et al.
Circulation|September 30, 2021
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating VariantsMarta Gigli, Davide Stolfo, Sharon L Graw, et al.
JACC. Heart Failure|July 18, 2025
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric StudyMaria Perotto, Alessia Paldino, Francesco Mazzarotto, et al.
European Journal of Heart Failure|December 9, 2022
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortalityMarianna Adamo, Matteo Pagnesi, Giulia Ghizzoni, et al.
European Heart Journal|June 29, 2022
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculatorAlexandros Protonotarios, Riccardo Bariani, Chiara Cappelletto, et al.
Journal of the American College of Cardiology|December 3, 2016
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic CardiomyopathiesMartín F Ortiz-Genga, Sofía Cuenca, Matteo Dal Ferro, et al.
JACC. Advances|May 13, 2025
The Diagnostic and Prognostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular CardiomyopathyLeonardo Calò, Cinzia Crescenzi, Andrea Di Marco, et al.
Vascular Pharmacology|December 1, 2025
ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of REVEAL risk scoreSilvia Papa, Michele D'Alto, Laura Scelsi, et al.
ESC Heart Failure|September 17, 2021
Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registryMateusz Sokolski, Sander Trenson, Justyna M Sokolska, et al.
JAMA Cardiology|February 12, 2025
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants, Marta Gigli, Davide Stolfo, et al.
Pageof 21

Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Circulation. Arrhythmia and Electrophysiology|January 29, 2026
Left Ventricular Late Gadolinium Enhancement for Arrhythmic Risk Prediction in ARVCCorrado De Marco, Babken Asatryan, Anneline S J M Te Riele, et al.
Circulation|September 30, 2021
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating VariantsMarta Gigli, Davide Stolfo, Sharon L Graw, et al.
JACC. Heart Failure|July 18, 2025
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric StudyMaria Perotto, Alessia Paldino, Francesco Mazzarotto, et al.
European Journal of Heart Failure|December 9, 2022
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortalityMarianna Adamo, Matteo Pagnesi, Giulia Ghizzoni, et al.
European Heart Journal|June 29, 2022
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculatorAlexandros Protonotarios, Riccardo Bariani, Chiara Cappelletto, et al.
Journal of the American College of Cardiology|December 3, 2016
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic CardiomyopathiesMartín F Ortiz-Genga, Sofía Cuenca, Matteo Dal Ferro, et al.
JACC. Advances|May 13, 2025
The Diagnostic and Prognostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular CardiomyopathyLeonardo Calò, Cinzia Crescenzi, Andrea Di Marco, et al.
Vascular Pharmacology|December 1, 2025
ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of REVEAL risk scoreSilvia Papa, Michele D'Alto, Laura Scelsi, et al.
ESC Heart Failure|September 17, 2021
Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registryMateusz Sokolski, Sander Trenson, Justyna M Sokolska, et al.
JAMA Cardiology|February 12, 2025
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants, Marta Gigli, Davide Stolfo, et al.
Pageof 21